Evidence check: Omega-3 Index in the context of blood sugar

The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and is primarily validated as a marker for cardiovascular risk. Regarding blood sugar regulation, the evidence is mixed and not robust. Some observational studies and small RCTs suggest that higher omega-3 intake may improve insulin sensitivity, especially in individuals with metabolic syndrome or inflammation. However, other trials, particularly in type 2 diabetes, show no significant effect on fasting glucose or HbA1c, and some even report a slight increase in fasting glucose with high doses. The Omega-3 Index itself has not been directly validated as a predictor of glycemic outcomes. Mechanistically, omega-3s may reduce inflammation and improve cell membrane fluidity, which could benefit insulin action, but the clinical translation is inconsistent. Overall, the evidence is moderate at best, with conflicting results. It is not recommended to rely solely on the Omega-3 Index for blood sugar management. Caution: high-dose omega-3 supplementation may worsen glycemic control in some diabetics. Consult a healthcare provider before making changes.